Preparing Patients for Treatment: Education, Administration and Adverse Effect Management in HER2+ Breast Cancer

Panelists discuss how patients are prepared for treatment, the adverse effects associated with different agents and combination regimens that they educate patients about, the process of administering treatment for HER2+ breast cancer, and the overall approach to monitoring and managing adverse effects throughout the treatment journey.

EP: 1.Overview of HER2 Breast Cancer

EP: 2.HER2+ Breast Cancer Diagnosis: Insights From Patients and Clinicians

EP: 3.Coordinating Care for HER+ Breast Cancer Patients: A Multidisciplinary Approach

EP: 4.Multidisciplinary Care of HER2+ Breast Cancer: A Patient Perspective

EP: 5.Tailoring Patient Education and Resources in HER2+ Breast Cancer

EP: 6.Navigating HER2+ Breast Cancer Treatment: A Patient's Journey

EP: 7.Navigating Systemic Therapy Options in HER2+ Breast Cancer

EP: 8.Key Insights from the HER2CLIMB Trial

EP: 9.Key Insights From the DEBBRAH and HER2CLIMB-02 Studies

EP: 10.BRIDGET Trial: Strategies in Maintenance Therapy for HER2+ Breast Cancer with Brain Metastases

Now Viewing

EP: 11.Preparing Patients for Treatment: Education, Administration and Adverse Effect Management in HER2+ Breast Cancer

EP: 12.Patient Perspectives on Managing Adverse Effects from Capecitabine, Trastuzumab, and Tucatinib

1. Dr Iyengar asks Odessa Williams: How do you prepare patients for before and during treatment?
   1. Based on the different agents and combination regimens, what side which adverse effects do you educate your patients on?
   2. Describe your process for administering treatment for patients with HER2+ breast cancer.
   3. What is your overall approach to monitoring and managing side adverse effects?

Recent Videos